Ocugen, Bharat Biotech's Partner, Asks US Authorities to Approve Emergency Use Authorisation for Covaxin for Children Below 18
Bharat Biotech's partner has requested the US authorities to approve emergency use authorisation of Covaxin in the states for children below the age of 18.
The approval for emergency use authorisation for Covaxin, COVID-19 vaccine developed by Bharat Biotech, has been requested by it's partner firm Ocugen in the US for children below the age of 18 years.
Dr Raches Ella, Bharat Biotech's Clinical Lead for COVID-19 Vaccines, Tweeted the Development:
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)